Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013687 · ClinicalTrials.gov registry record · Phase 1
Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults
A Phase 1 study, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT02013687: Completed Phase 1 study, sponsored by Fraunhofer, Center for Molecular Biotechnology.
NCT02013687 is a Phase 1 study that has completed, run by Fraunhofer, Center for Molecular Biotechnology. The registered enrollment target is 44 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02013687, a Phase 1 study, has completed, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is a Phase 1, dose escalation, first-in-human study designed primarily to evaluate the safety of the purified plant-derived Pfs25 VLP combined with Alhydrogel adjuvant
Interventions
- BIOLOGICAL Pfs25 VLP- FhCMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
What the finished NCT02013687 record still lists
NCT02013687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 1 intervention - of which Pfs25 VLP- FhCMB is the first listed.
NCT02013687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02013687 about?
NCT02013687 is a clinical study titled "Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults". This study is a Phase 1, dose escalation, first-in-human study designed primarily to evaluate the safety of the purified plant-derived Pfs25 VLP combined with Alhydrogel adjuvant
What is the current status of trial NCT02013687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2013-10. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02013687?
The interventions under investigation include: Pfs25 VLP- FhCMB (BIOLOGICAL).
Who is sponsoring clinical trial NCT02013687?
This trial is sponsored by Fraunhofer, Center for Molecular Biotechnology, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02013687's enrollment target sits among peer trials
44 1086th of 2000 higher than 901 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia